Ember Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
135 E 57th St Fl 24, New York City, New ...Phone Number
(646) 406-6243Website
www.embertx.comRevenue
<$5 MillionStock Symbol
EMBTIndustry
About Ember Therapeutics
Ember Therapeutics Org Chart
Is Ember Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Ember Therapeutics recently announced quarterly report
Product Launch: Get notified when Ember Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Click to see if Ember Therapeutics had a recent Job posting/layoffs
Check if Ember Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Ember Therapeutics is spiking on competitors!
Ember Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Ember Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Ember Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Ember Therapeutics
Find 3 more new buyers
Compare Similar Companies to Ember Therapeutics
Compare insights from companies similar to Ember Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ember Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ember Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ember Therapeutics.
Ember Therapeutics financials insights
Gather financial insights about Ember Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1M
Ember Therapeutics Tech Stack
A closer look at the technologies used by Ember Therapeutics
Ember Therapeutics News & Media
Ember Therapeutics to divest OP-1 product family and related assets to Viscogliosi Brothers
New York City-based Ember Therapeutics, a biopharmaceutical company, has agreed to sell its OP-1 product family and related assets, to Viscogliosi Brothers LLC, a private equity firm focused on developing neuromusculoskeletal technologies. No financial terms were disclosed.Ember Therapeutics Enters Into Agreement to Divest OP-1 Portfolio Program to Viscogliosi Brothers, LLC
NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Ember Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the clinical application of Bone Morphogenetic Protein-7 (BMP-7), announced today that it has entered into a letter of intent with Viscogliosi Brothers, LLC (VB), a...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ember Therapeutics
Ember Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. They are known for their product Migralex, the first over-the-counter headache and pain medication that includes Magnesium as an active ingredient. The company is also involved in research related to BMP-7 and its potential application... Read More